Journal of Vascular Surgery
Volume 48, Issue 4 , Pages 815-820 , October 2008

Aortoiliac aneurysms infected by Campylobacter fetus

  • Frédéric Cochennec, MD

      Affiliations

    • Department of Vascular Surgery, Henri Mondor Hospital, Créteil, France
    • Corresponding Author InformationReprint requests: Frédéric Cochennec, Henri Mondor Hospital, 51 av du Maréchal de Lattre de Tassigny, 94000 Créteil, France
    • ,
  • Laure Gazaigne, MD

      Affiliations

    • Department of Medical Microbiology and Infectious Diseases, Henri Mondor Hospital, Créteil, France
    • ,
  • Philippe Lesprit, MD

      Affiliations

    • Department of Medical Microbiology and Infectious Diseases, Henri Mondor Hospital, Créteil, France
    • ,
  • Pascal Desgranges, MD, PhD

      Affiliations

    • Department of Vascular Surgery, Henri Mondor Hospital, Créteil, France
    • ,
  • Eric Allaire, MD, PhD

      Affiliations

    • Department of Vascular Surgery, Henri Mondor Hospital, Créteil, France
    • ,
  • Jean-Pierre Becquemin, MD, FRCS

      Affiliations

    • Department of Vascular Surgery, Henri Mondor Hospital, Créteil, France

Received 12 March 2008 ,Accepted 28 May 2008.

References 

  1. Brown SL, Busuttil RW, Baker JD, Machleder HI, Moore WS, Barker WF. Bacteriologic and surgical determinants of survival in patients with mycotic aneurysms. J Vasc Surg. 1984;1:541–547
  2. Jarrett F, Darling RC, Mundth ED, Austen WG. Experience with infected aneurysms of the abdominal aorta. Arch Surg. 1975;110:1281–1286
  3. Dolev E, Altmann G, Padeh B. Vibrio fetus septicemia (A case report). Isr J Med Sci. 1971;7:1188–1191
  4. File TM, Barnishan J, Fass RJ. C fetus sepsis with mycotic aortic aneurysm. Arch Pathol Lab Med. 1979;103:143–145
  5. Taylor PR, Weinstein WM, Bryner JH. C fetus infection in human subjects: association with raw milk. Am J Med. 1979;66:779–783
  6. Anolik JR, Mildvan D, Winter JW, Puttlitz D, Rubenstein S, Lozman H. Mycotic aortic aneurysm (A complication of C fetus septicemia). Arch Intern Med. 1983;143:609–610
  7. Marty AT, Webb TA, Stubbs KG, Penkava RR. Inflammatory abdominal aortic aneurysm infected by C fetus. JAMA. 1983;249:1190–1192
  8. Blabey RG, Parry MF, Bull SM, Weed CB. Mycotic aneurysm of the abdominal aorta: successful management of C fetus aortitis. Conn Med. 1983;47:129–130
  9. Righter J, Woods JM. Campylobacter and endovascular lesions. Can J Surg. 1985;28:451–452
  10. Perry MO. Infected aortic aneurysms. J Vasc Surg. 1985;2:597–599
  11. Rutherford EJ, Eakins JW, Maxwell JG, Tackett AD. Abdominal aortic aneurysm infected with C fetus subspecies fetus. J Vasc Surg. 1989;10:193–197
  12. Jacobs J, Van Lierde J, Nevelsteen A, Vermylen J, Verbist L. C fetus subspecies fetus infection of an abdominal aneurysm. Acta Clin Belg. 1989;44:123–128
  13. Kato R, Ohta T, Kazui H, Kondo M, Naiki K, Tsuchioka H. C fetus infection of abdominal aortic aneurysm. J Cardiovasc Surg (Torino). 1990;31:756–759
  14. Allerberger F, Kasten MJ, Anhalt JP. C fetus subspecies fetus infection. Klin Wochenschr. 1991;69:813–816
  15. Grollier G, Burucoa C, Ricco JB, Pezennec L, Fauchere JL. Isolation and immunogenicity of C fetus subsp. fetus from an abdominal aortic aneurysm. Eur J Clin Microbiol Infect Dis. 1993;12:847–849
  16. Mii S, Tanaka K, Furugaki K, Sakata H, Katoh H, Mori A. Infected abdominal aortic aneurysm caused by C fetus subspecies fetus: report of a case. Surg Today. 1998;28:661–664
  17. Tran JK, de Virgilio C. Management of an abdominal aortic aneurysm infected with C fetus: a case report. Ann Vasc Surg. 2007;21:137–142
  18. Bosshard PP, Kronenberg A, Zbinden R, Ruef C, Bottger EC, Altwegg M. Etiologic diagnosis of infective endocarditis by broad-range polymerase chain reaction: a 3-year experience. Clin Infect Dis. 2003;37:167–172
  19. Comite de l'Antibiogramme de la Societe Francaise de Microbiologie report 2003. Int J Antimicrob Agents. 2003;21:364–391
  20. Guerrant RL, Lahita RG, Winn WC, Roberts RB. Campylobacteriosis in man: pathogenic mechanisms and review of 91 bloodstream infections. Am J Med. 1978;65:584–592
  21. Righter J, Wells WA, Hart GD, McNeely DJ. Relapsing septicemia caused by C fetus subsp. fetus. Can Med Assoc J. 1983;128:686–689
  22. Loeb H, Bettag JL, Yung NK, King S, Bronsky D. Vibrio fetus endocarditis (Report of 2 cases). Am Heart J. 1966;71:381–386
  23. Killam HA, Crowder JG, White AC, Edmonds JH. Pericarditis due to Vibrio fetus. Am J Cardiol. 1966;17:723–728
  24. Vesely D, MacIntyre S, Ratzan KR. Bilateral deep brachial vein thrombophlebitis due to vibrio fetus. Arch Intern Med. 1975;135:994–995
  25. Gubina M, Zajc-Satler J, Mehle J, Drinovec B, Pikelj F, Radsel-Medvescek A, et al. Septicaemia and meningitis with C fetus subspecies intestinalis. Infection. 1976;4:115–118
  26. Kilo C, Hagemann PO, Marzi J. Septic arthritis and bacteremia due to Vibrio fetus: report of an unusual case and review of the literature. Am J Med. 1965;38:962–971
  27. Bracikowski JP, Hess IE, Rein MF. Campylobacter osteomyelitis. South Med J. 1984;77:1611–1613
  28. Francioli P, Herzstein J, Grob JP, Vallotton JJ, Mombelli G, Glauser MP. C fetus subspecies fetus bacteremia. Arch Intern Med. 1985;145:289–292
  29. Targan SR, Chow AW, Guze LB. C fetus associated with pulmonary abscess and empyema. Chest. 1977;71:105–108
  30. Lozano P, Rimbau EM, Martinez S, Ribas MA, Gomez FT. C fetus infection of a previously excluded popliteal aneurysm. Eur J Vasc Endovasc Surg. 1999;18:86–88
  31. Tremblay C, Gaudreau C, Lorange M. Epidemiology and antimicrobial susceptibilities of 111 C fetus subsp. fetus strains isolated in Quebec, Canada, from 1983 to 2000. J Clin Microbiol. 2003;41:463–466
  32. Morrison VA, Lloyd BK, Chia JK, Tuazon CU. Cardiovascular and bacteremic manifestations of C fetus infection: case report and review. Rev Infect Dis. 1990;12:387–392
  33. Macedo TA, Stanson AW, Oderich GS, Johnson CM, Panneton JM, Tie ML. Infected aortic aneurysms: imaging findings. Radiology. 2004;231:250–257
  34. Pasic M, Carrel T, Tonz M, Vogt P, von Segesser L, Turina M. Mycotic aneurysm of the abdominal aorta: extra-anatomic versus in situ reconstruction. Cardiovasc Surg. 1993;1:48–52
  35. Fichelle JM, Tabet G, Cormier P, Farkas JC, Laurian C, Gigou F, et al. Infected infrarenal aortic aneurysms: when is in situ reconstruction safe?. J Vasc Surg. 1993;17:635–645
  36. Yeager RA, Taylor LM, Moneta GL, Edwards JM, Nicoloff AD, McConnell DB, et al. Improved results with conventional management of infrarenal aortic infection. J Vasc Surg. 1999;30:76–83
  37. Bacourt F, Koskas F. Axillobifemoral bypass and aortic exclusion for vascular septic lesions: a multicenter retrospective study of 98 cases (French University Association for Research in Surgery). Ann Vasc Surg. 1992;6:119–126
  38. Bandyk DF, Novotney ML, Back MR, Johnson BL, Schmacht DC. Expanded application of in situ replacement for prosthetic graft infection. J Vasc Surg. 2001;34:411–419
  39. O'Hara PJ, Hertzer NR, Beven EG, Krajewski LP. Surgical management of infected abdominal aortic grafts: review of a 25-year experience. J Vasc Surg. 1986;3:725–731
  40. Sharp WJ, Hoballah JJ, Mohan CR, Kresowik TF, Martinasewic M, Chalmers AT, et al. The management of the infected aortic prosthesis: a current decade of experience. J Vasc Surg. 1994;19:844–850
  41. Noel AA, Gloviczki P, Cherry KJ, Safi H, Goldstone J, Morasch MD, et al. Abdominal aortic reconstruction in infected fields: early results of the United States cryopreserved aortic allograft registry. J Vasc Surg. 2002;35:847–852
  42. Verhelst R, Lacroix V, Vraux H, Lavigne JP, Vandamme H, Limet R, et al. Use of cryopreserved arterial homografts for management of infected prosthetic grafts: a multicentric study. Ann Vasc Surg. 2000;14:602–607
  43. Vogt PR, Brunner-LaRocca HP, Lachat M, Ruef C, Turina MI. Technical details with the use of cryopreserved arterial allografts for aortic infection: influence on early and midterm mortality. J Vasc Surg. 2002;35:80–86
  44. Leseche G, Castier Y, Petit MD, Bertrand P, Kitzis M, Mussot S, et al. Long-term results of cryopreserved arterial allograft reconstruction in infected prosthetic grafts and mycotic aneurysms of the abdominal aorta. J Vasc Surg. 2001;34:616–622
  45. Kieffer E, Gomes D, Chiche L, Fleron MH, Koskas F, Bahnini A. Allograft replacement for infrarenal aortic graft infection: early and late results in 179 patients. J Vasc Surg. 2004;39:1009–1017
  46. Nevelsteen A, Lacroix H, Suy R. Autogenous reconstruction with the lower extremity deep veins: an alternative treatment of prosthetic infection after reconstructive surgery for aortoiliac disease. J Vasc Surg. 1995;22:129–134
  47. Kyriakides C, Kan Y, Kerle M, Cheshire NJ, Mansfield AO, Wolfe JH. 11-year experience with anatomical and extra-anatomical repair of mycotic aortic aneurysms. Eur J Vasc Endovasc Surg. 2004;27:585–589
  48. Batt M, Magne JL, Alric P, Muzj A, Ruotolo C, Ljungstrom KG, et al. In situ revascularization with silver-coated polyester grafts to treat aortic infection: early and midterm results. J Vasc Surg. 2003;38:983–989
  49. Corso JE, Kasirajan K, Milner R. Endovascular management of ruptured, mycotic abdominal aortic aneurysm. Am Surg. 2005;71:515–517
  50. Ting AC, Cheng SW, Ho P, Poon JT, Tsu JH. Surgical treatment of infected aneurysms and pseudoaneurysms of the thoracic and abdominal aorta. Am J Surg. 2005;189:150–154
  51. Smith JJ, Taylor PR. Endovascular treatment of mycotic aneurysms of the thoracic and abdominal aorta: the need for level I evidence. Eur J Vasc Endovasc Surg. 2004;27:569–570
  52. Forbes TL, Harding GE. Endovascular repair of Salmonella-infected abdominal aortic aneurysms: a word of caution. J Vasc Surg. 2006;44:198–200
  53. Tremblay C, Gaudreau C. Antimicrobial susceptibility testing of 59 strains of C fetus subsp. fetus. Antimicrob Agents Chemother. 1998;42:1847–1849

 Competition of interest: none.

PII: S0741-5214(08)00924-5

doi: 10.1016/j.jvs.2008.05.076

Journal of Vascular Surgery
Volume 48, Issue 4 , Pages 815-820 , October 2008

Article Tools

* Image Usage & Resolution